<p>To say that the medical world’s view of psychedelics has changed would be a vast understatement. Until about two decades ago, drugs like LSD and psilocybin—the active compound in psychedelic mushrooms—were considered dangerous party drugs. Then, a small group of scientists began reconsidering the therapeutic value of the compounds, known for centuries in many non-industrial cultures. In 2000, doctors at Johns Hopkins got regulatory approval to study the drugs. Since then, doctors there and elsewhere have shown that psychedelics can help people quit smoking, quit drinking, ease anxiety, and lift depression. PNI started its Treatment & Research In Psychedelics (TRIP) program in 2019, under the direction of Dr. Keith Heinzerling. So far, TRIP has completed three studies of psychedelics which are difficult to do because the drugs are still illegal under federal law. More studies particularly focusing on depression are underway. Working on those trials has made Dr. Heinzerling one of the foremost experts on psychedelics. Listen to the episode to learn more about the “psychedelic renaissance,” now in its 25th year, from a practitioner who has a thoughtful take on the promise of these once-shunned compounds.</p>

To say that the medical world’s view of psychedelics has changed would be a vast understatement. Until about two decades ago, drugs like LSD and psilocybin—the active compound in psychedelic mushrooms—were considered dangerous party drugs. Then, a small group of scientists began reconsidering the therapeutic value of the compounds, known for centuries in many non-industrial cultures. In 2000, doctors at Johns Hopkins got regulatory approval to study the drugs. Since then, doctors there and elsewhere have shown that psychedelics can help people quit smoking, quit drinking, ease anxiety, and lift depression. PNI started its Treatment & Research In Psychedelics (TRIP) program in 2019, under the direction of Dr. Keith Heinzerling. So far, TRIP has completed three studies of psychedelics which are difficult to do because the drugs are still illegal under federal law. More studies particularly focusing on depression are underway. Working on those trials has made Dr. Heinzerling one of the foremost experts on psychedelics. Listen to the episode to learn more about the “psychedelic renaissance,” now in its 25th year, from a practitioner who has a thoughtful take on the promise of these once-shunned compounds.

<p>To say that the medical world’s view of psychedelics has changed would be a vast understatement. Until about two decades ago, drugs like LSD and psilocybin—the active compound in psychedelic mushrooms—were considered dangerous party drugs. Then, a small group of scientists began reconsidering the therapeutic value of the compounds, known for centuries in many non-industrial cultures. In 2000, doctors at Johns Hopkins got regulatory approval to study the drugs. Since then, doctors there and elsewhere have shown that psychedelics can help people quit smoking, quit drinking, ease anxiety, and lift depression. PNI started its Treatment &amp; Research In Psychedelics (TRIP) program in 2019, under the direction of Dr. Keith Heinzerling. So far, TRIP has completed three studies of psychedelics which are difficult to do because the drugs are still illegal under federal law. More studies particularly focusing on depression are underway. Working on those trials has made Dr. Heinzerling one of the foremost experts on psychedelics. Listen to the episode to learn more about the “psychedelic renaissance,” now in its 25th year, from a practitioner who has a thoughtful take on the promise of these once-shunned compounds.</p>

63. The Psychedelic Renaissance Turns 25 | Dr. Keith Heinzerling

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. You’ll go deep into the brain and beyond, exploring the neurological processes and structures that control our health, hormones, behaviors, movements, moods, and emotions. You’ll learn about new therapies that are giving hope for sufferers of the most challenging diseases, and you’ll hear about some habits you can develop to keep your brain in good working order for years to come. We’ll show you why patients from around the world are coming to Pacific Neuroscience Institute for novel treatments that are in many instances, available at few other institutions.

pacificneuro.org  |  (310) 582-7640

Think Neuro’s has two co-hosts, Anthony Effinger and Dan Fost.

Anthony Effinger is an award-winning journalist who is fascinated with neuroscience and the workings of the brain. Anthony spent 24 years at Bloomberg News, where he covered money and finance, with deep forays into science and health. In 2006, the Association of Health Care Journalists awarded him first prize for Playing the Odds, an in-depth piece on the changing strategies used to treat prostate cancer. These days, he is a staff writer at Willamette Week, a Pulitzer Prize-winning newspaper in Portland, Oregon, where he lives with his wife and two children. He won the 2022 award for health care journalism from the Association of Alternative Newsmedia for his piece on the disproven Covid remedy ivermectin and the anti-vaxx Portland biologist who was its biggest booster.

Dan Fost is a veteran journalist who has written for the New York Times, Los Angeles Times, and the Washington Post. A former staff writer for the San Francisco Chronicle, he covers health, science, and technology, making complex subjects accessible to a broad audience. Dan has written extensively for the University of California, San Francisco, one of the nation’s leading health science universities, where he’s reported on leading scientists (including Nobel Prize winners), global health, and biotechnology innovations that have led to the launch of new companies. Dan is the author of “Giants Past and Present,” a book about the San Francisco baseball team. A native of New Jersey and a graduate of Boston University, Dan lives in Marin County, Calif., with his wife. They have one adult son.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. You’ll go deep into the brain and beyond, exploring the neurological processes and structures that control our health, hormones, behaviors, movements, moods, and emotions. You’ll learn about new therapies that are giving hope for sufferers of the most challenging diseases, and you’ll hear about some habits you can develop to keep your brain in good working order for years to come. We’ll show you why patients from around the world are coming to Pacific Neuroscience Institute for novel treatments that are in many instances, available at few other institutions. pacificneuro.org | (310) 582-7640 Think Neuro’s has two co-hosts, Anthony Effinger and Dan Fost. Anthony Effinger is an award-winning journalist who is fascinated with neuroscience and the workings of the brain. Anthony spent 24 years at Bloomberg News, where he covered money and finance, with deep forays into science and health. In 2006, the Association of Health Care Journalists awarded him first prize for Playing the Odds, an in-depth piece on the changing strategies used to treat prostate cancer. These days, he is a staff writer at Willamette Week, a Pulitzer Prize-winning newspaper in Portland, Oregon, where he lives with his wife and two children. He won the 2022 award for health care journalism from the Association of Alternative Newsmedia for his piece on the disproven Covid remedy ivermectin and the anti-vaxx Portland biologist who was its biggest booster. Dan Fost is a veteran journalist who has written for the New York Times, Los Angeles Times, and the Washington Post. A former staff writer for the San Francisco Chronicle, he covers health, science, and technology, making complex subjects accessible to a broad audience. Dan has written extensively for the University of California, San Francisco, one of the nation’s leading health science universities, where he’s reported on leading scientists (including Nobel Prize winners), global health, and biotechnology innovations that have led to the launch of new companies. Dan is the author of “Giants Past and Present,” a book about the San Francisco baseball team. A native of New Jersey and a graduate of Boston University, Dan lives in Marin County, Calif., with his wife. They have one adult son.

Share 63. The Psychedelic Renaissance Turns 25 | Dr. Keith Heinzerling

Sign up to save your podcasts

63. The Psychedelic Renaissance Turns 25 | Dr. Keith Heinzerling

63. The Psychedelic Renaissance Turns 25 | Dr. Keith Heinzerling

More shows like Think Neuro

This American Life

Freakonomics Radio

Hidden Brain

The Cabral Concept

JAMA Clinical Reviews

The Daily

Wonder Podcast: Empowering Women Entrepreneurs to Change the World

Essential Tremors

Zero to Finals Medical Revision Podcast

Huberman Lab

Primary Care Voice